nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.13	0.223	CbGbCtD
Eszopiclone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0748	0.129	CbGbCtD
Eszopiclone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0688	0.118	CbGbCtD
Eszopiclone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0688	0.118	CbGbCtD
Eszopiclone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0528	0.0908	CbGbCtD
Eszopiclone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0522	0.0897	CbGbCtD
Eszopiclone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0357	0.0613	CbGbCtD
Eszopiclone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.034	0.0585	CbGbCtD
Eszopiclone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0303	0.0521	CbGbCtD
Eszopiclone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0306	CbGbCtD
Eszopiclone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0168	0.0289	CbGbCtD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000526	0.00592	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000517	0.00582	CbGpPWpGaD
Eszopiclone—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000517	0.00581	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000505	0.00568	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000493	0.00554	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000492	0.00553	CbGpPWpGaD
Eszopiclone—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000491	0.00552	CbGpPWpGaD
Eszopiclone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000488	0.00549	CbGpPWpGaD
Eszopiclone—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000479	0.00539	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000466	0.00525	CbGpPWpGaD
Eszopiclone—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000461	0.00519	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000453	0.0051	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00045	0.00506	CbGpPWpGaD
Eszopiclone—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000446	0.00502	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000441	0.00496	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000437	0.00492	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000429	0.00483	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000429	0.00483	CbGpPWpGaD
Eszopiclone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.00476	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000422	0.00474	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000416	0.00468	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000415	0.00467	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000411	0.00463	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000403	0.00453	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000402	0.00452	CbGpPWpGaD
Eszopiclone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00121	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00121	CcSEcCtD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000396	0.00445	CbGpPWpGaD
Eszopiclone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.0012	CcSEcCtD
Eszopiclone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000394	0.0012	CcSEcCtD
Eszopiclone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.0012	CcSEcCtD
Eszopiclone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00119	CcSEcCtD
Eszopiclone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00119	CcSEcCtD
Eszopiclone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00119	CcSEcCtD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000393	0.00442	CbGpPWpGaD
Eszopiclone—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00039	0.00439	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000389	0.00437	CbGpPWpGaD
Eszopiclone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00118	CcSEcCtD
Eszopiclone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00117	CcSEcCtD
Eszopiclone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00117	CcSEcCtD
Eszopiclone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00117	CcSEcCtD
Eszopiclone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00117	CcSEcCtD
Eszopiclone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00117	CcSEcCtD
Eszopiclone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00117	CcSEcCtD
Eszopiclone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000385	0.00434	CbGpPWpGaD
Eszopiclone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00117	CcSEcCtD
Eszopiclone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00116	CcSEcCtD
Eszopiclone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00116	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000383	0.0043	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000383	0.0043	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000381	0.00429	CbGpPWpGaD
Eszopiclone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00115	CcSEcCtD
Eszopiclone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00115	CcSEcCtD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000379	0.00427	CbGpPWpGaD
Eszopiclone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00115	CcSEcCtD
Eszopiclone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00115	CcSEcCtD
Eszopiclone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00115	CcSEcCtD
Eszopiclone—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000378	0.00425	CbGpPWpGaD
Eszopiclone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00114	CcSEcCtD
Eszopiclone—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00114	CcSEcCtD
Eszopiclone—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000375	0.00422	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000374	0.00421	CbGpPWpGaD
Eszopiclone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00113	CcSEcCtD
Eszopiclone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00113	CcSEcCtD
Eszopiclone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00113	CcSEcCtD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00037	0.00416	CbGpPWpGaD
Eszopiclone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00112	CcSEcCtD
Eszopiclone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00112	CcSEcCtD
Eszopiclone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000369	0.00415	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000368	0.00414	CbGpPWpGaD
Eszopiclone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00111	CcSEcCtD
Eszopiclone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00111	CcSEcCtD
Eszopiclone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.00111	CcSEcCtD
Eszopiclone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00111	CcSEcCtD
Eszopiclone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00111	CcSEcCtD
Eszopiclone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00111	CcSEcCtD
Eszopiclone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.0011	CcSEcCtD
Eszopiclone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.0011	CcSEcCtD
Eszopiclone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.0011	CcSEcCtD
Eszopiclone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000362	0.0011	CcSEcCtD
Eszopiclone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.0011	CcSEcCtD
Eszopiclone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00109	CcSEcCtD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00405	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000359	0.00404	CbGpPWpGaD
Eszopiclone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00109	CcSEcCtD
Eszopiclone—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000357	0.00401	CbGpPWpGaD
Eszopiclone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.00399	CbGpPWpGaD
Eszopiclone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000352	0.00107	CcSEcCtD
Eszopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000351	0.00395	CbGpPWpGaD
Eszopiclone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00107	CcSEcCtD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00035	0.00394	CbGpPWpGaD
Eszopiclone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00106	CcSEcCtD
Eszopiclone—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000347	0.00391	CbGpPWpGaD
Eszopiclone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.00105	CcSEcCtD
Eszopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000344	0.00387	CbGpPWpGaD
Eszopiclone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00104	CcSEcCtD
Eszopiclone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00104	CcSEcCtD
Eszopiclone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00383	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00034	0.00382	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00103	CcSEcCtD
Eszopiclone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00103	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00103	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00103	CcSEcCtD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000338	0.0038	CbGpPWpGaD
Eszopiclone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00102	CcSEcCtD
Eszopiclone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00102	CcSEcCtD
Eszopiclone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00102	CcSEcCtD
Eszopiclone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00101	CcSEcCtD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000334	0.00376	CbGpPWpGaD
Eszopiclone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00101	CcSEcCtD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000332	0.00373	CbGpPWpGaD
Eszopiclone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00101	CcSEcCtD
Eszopiclone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00101	CcSEcCtD
Eszopiclone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.001	CcSEcCtD
Eszopiclone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000331	0.001	CcSEcCtD
Eszopiclone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.001	CcSEcCtD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000328	0.0037	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000328	0.00369	CbGpPWpGaD
Eszopiclone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000327	0.000993	CcSEcCtD
Eszopiclone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.000993	CcSEcCtD
Eszopiclone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000327	0.000993	CcSEcCtD
Eszopiclone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.000989	CcSEcCtD
Eszopiclone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000983	CcSEcCtD
Eszopiclone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000324	0.000983	CcSEcCtD
Eszopiclone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00098	CcSEcCtD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000323	0.00363	CbGpPWpGaD
Eszopiclone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.000978	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000974	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000974	CcSEcCtD
Eszopiclone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000973	CcSEcCtD
Eszopiclone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000973	CcSEcCtD
Eszopiclone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000973	CcSEcCtD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00032	0.0036	CbGpPWpGaD
Eszopiclone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.000971	CcSEcCtD
Eszopiclone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.000965	CcSEcCtD
Eszopiclone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.000965	CcSEcCtD
Eszopiclone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000318	0.000965	CcSEcCtD
Eszopiclone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000318	0.000965	CcSEcCtD
Eszopiclone—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000318	0.00358	CbGpPWpGaD
Eszopiclone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000964	CcSEcCtD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000317	0.00357	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000317	0.00357	CbGpPWpGaD
Eszopiclone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000962	CcSEcCtD
Eszopiclone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000962	CcSEcCtD
Eszopiclone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000957	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000314	0.000954	CcSEcCtD
Eszopiclone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000314	0.000953	CcSEcCtD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000314	0.00353	CbGpPWpGaD
Eszopiclone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00095	CcSEcCtD
Eszopiclone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.000947	CcSEcCtD
Eszopiclone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000311	0.000945	CcSEcCtD
Eszopiclone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.000943	CcSEcCtD
Eszopiclone—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000311	0.00349	CbGpPWpGaD
Eszopiclone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.000939	CcSEcCtD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000309	0.00348	CbGpPWpGaD
Eszopiclone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000938	CcSEcCtD
Eszopiclone—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000309	0.00347	CbGpPWpGaD
Eszopiclone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.000935	CcSEcCtD
Eszopiclone—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000308	0.00346	CbGpPWpGaD
Eszopiclone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.000934	CcSEcCtD
Eszopiclone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.00346	CbGpPWpGaD
Eszopiclone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.000931	CcSEcCtD
Eszopiclone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00093	CcSEcCtD
Eszopiclone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00093	CcSEcCtD
Eszopiclone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.000929	CcSEcCtD
Eszopiclone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.000926	CcSEcCtD
Eszopiclone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.000925	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000304	0.000923	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.000923	CcSEcCtD
Eszopiclone—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000303	0.00341	CbGpPWpGaD
Eszopiclone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00092	CcSEcCtD
Eszopiclone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000919	CcSEcCtD
Eszopiclone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.000911	CcSEcCtD
Eszopiclone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.000911	CcSEcCtD
Eszopiclone—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000298	0.00335	CbGpPWpGaD
Eszopiclone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000904	CcSEcCtD
Eszopiclone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000904	CcSEcCtD
Eszopiclone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000295	0.00332	CbGpPWpGaD
Eszopiclone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000295	0.000896	CcSEcCtD
Eszopiclone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.000896	CcSEcCtD
Eszopiclone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000892	CcSEcCtD
Eszopiclone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000892	CcSEcCtD
Eszopiclone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000892	CcSEcCtD
Eszopiclone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000892	CcSEcCtD
Eszopiclone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000889	CcSEcCtD
Eszopiclone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.000889	CcSEcCtD
Eszopiclone—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000291	0.00327	CbGpPWpGaD
Eszopiclone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.000882	CcSEcCtD
Eszopiclone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.000881	CcSEcCtD
Eszopiclone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.000881	CcSEcCtD
Eszopiclone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000289	0.000878	CcSEcCtD
Eszopiclone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000878	CcSEcCtD
Eszopiclone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.000876	CcSEcCtD
Eszopiclone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000874	CcSEcCtD
Eszopiclone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000874	CcSEcCtD
Eszopiclone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000872	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000871	CcSEcCtD
Eszopiclone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000862	CcSEcCtD
Eszopiclone—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000283	0.00319	CbGpPWpGaD
Eszopiclone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000856	CcSEcCtD
Eszopiclone—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00028	0.00315	CbGpPWpGaD
Eszopiclone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.00315	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00028	0.00315	CbGpPWpGaD
Eszopiclone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000846	CcSEcCtD
Eszopiclone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000842	CcSEcCtD
Eszopiclone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000842	CcSEcCtD
Eszopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000274	0.00308	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000831	CcSEcCtD
Eszopiclone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000831	CcSEcCtD
Eszopiclone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.000831	CcSEcCtD
Eszopiclone—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000828	CcSEcCtD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000272	0.00305	CbGpPWpGaD
Eszopiclone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000822	CcSEcCtD
Eszopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.00304	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00027	0.00304	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000268	0.000814	CcSEcCtD
Eszopiclone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00081	CcSEcCtD
Eszopiclone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00081	CcSEcCtD
Eszopiclone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000263	0.000798	CcSEcCtD
Eszopiclone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.000798	CcSEcCtD
Eszopiclone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000797	CcSEcCtD
Eszopiclone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000261	0.000793	CcSEcCtD
Eszopiclone—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000259	0.00291	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000785	CcSEcCtD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.0029	CbGpPWpGaD
Eszopiclone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000258	0.000782	CcSEcCtD
Eszopiclone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.0029	CbGpPWpGaD
Eszopiclone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.000772	CcSEcCtD
Eszopiclone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000254	0.000772	CcSEcCtD
Eszopiclone—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000254	0.00286	CbGpPWpGaD
Eszopiclone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.000764	CcSEcCtD
Eszopiclone—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000252	0.00283	CbGpPWpGaD
Eszopiclone—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000251	0.00282	CbGpPWpGaD
Eszopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00025	0.00281	CbGpPWpGaD
Eszopiclone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000249	0.000756	CcSEcCtD
Eszopiclone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.000754	CcSEcCtD
Eszopiclone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00278	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000247	0.00278	CbGpPWpGaD
Eszopiclone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.000746	CcSEcCtD
Eszopiclone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000246	0.000746	CcSEcCtD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000245	0.00276	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000243	0.00273	CbGpPWpGaD
Eszopiclone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000731	CcSEcCtD
Eszopiclone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.000729	CcSEcCtD
Eszopiclone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000719	CcSEcCtD
Eszopiclone—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000237	0.00267	CbGpPWpGaD
Eszopiclone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000717	CcSEcCtD
Eszopiclone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000717	CcSEcCtD
Eszopiclone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000712	CcSEcCtD
Eszopiclone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000712	CcSEcCtD
Eszopiclone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000711	CcSEcCtD
Eszopiclone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000711	CcSEcCtD
Eszopiclone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000711	CcSEcCtD
Eszopiclone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000233	0.000707	CcSEcCtD
Eszopiclone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.000707	CcSEcCtD
Eszopiclone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000707	CcSEcCtD
Eszopiclone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.000706	CcSEcCtD
Eszopiclone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.000705	CcSEcCtD
Eszopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.00261	CbGpPWpGaD
Eszopiclone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000703	CcSEcCtD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00023	0.00259	CbGpPWpGaD
Eszopiclone—Rash—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000697	CcSEcCtD
Eszopiclone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000696	CcSEcCtD
Eszopiclone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000695	CcSEcCtD
Eszopiclone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000694	CcSEcCtD
Eszopiclone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000228	0.000692	CcSEcCtD
Eszopiclone—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000228	0.00257	CbGpPWpGaD
Eszopiclone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000684	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000683	CcSEcCtD
Eszopiclone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000677	CcSEcCtD
Eszopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000223	0.00251	CbGpPWpGaD
Eszopiclone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000675	CcSEcCtD
Eszopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000222	0.0025	CbGpPWpGaD
Eszopiclone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000673	CcSEcCtD
Eszopiclone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000672	CcSEcCtD
Eszopiclone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000671	CcSEcCtD
Eszopiclone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00067	CcSEcCtD
Eszopiclone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00067	CcSEcCtD
Eszopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00248	CbGpPWpGaD
Eszopiclone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.000668	CcSEcCtD
Eszopiclone—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00022	0.00247	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000217	0.00244	CbGpPWpGaD
Eszopiclone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000216	0.000657	CcSEcCtD
Eszopiclone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000649	CcSEcCtD
Eszopiclone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000647	CcSEcCtD
Eszopiclone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000633	CcSEcCtD
Eszopiclone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00063	CcSEcCtD
Eszopiclone—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000207	0.00233	CbGpPWpGaD
Eszopiclone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000622	CcSEcCtD
Eszopiclone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000611	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000201	0.00226	CbGpPWpGaD
Eszopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00224	CbGpPWpGaD
Eszopiclone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000596	CcSEcCtD
Eszopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00221	CbGpPWpGaD
Eszopiclone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000591	CcSEcCtD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.00211	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00206	CbGpPWpGaD
Eszopiclone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000553	CcSEcCtD
Eszopiclone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000552	CcSEcCtD
Eszopiclone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.00205	CbGpPWpGaD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00203	CbGpPWpGaD
Eszopiclone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000549	CcSEcCtD
Eszopiclone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000523	CcSEcCtD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00017	0.00191	CbGpPWpGaD
Eszopiclone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000513	CcSEcCtD
Eszopiclone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000505	CcSEcCtD
Eszopiclone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000504	CcSEcCtD
Eszopiclone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000503	CcSEcCtD
Eszopiclone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000165	0.0005	CcSEcCtD
Eszopiclone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000497	CcSEcCtD
Eszopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000162	0.00182	CbGpPWpGaD
Eszopiclone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000491	CcSEcCtD
Eszopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00182	CbGpPWpGaD
Eszopiclone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000489	CcSEcCtD
Eszopiclone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000486	CcSEcCtD
Eszopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.0018	CbGpPWpGaD
Eszopiclone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000471	CcSEcCtD
Eszopiclone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00047	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000155	0.00174	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000155	0.00174	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000154	0.00174	CbGpPWpGaD
Eszopiclone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000463	CcSEcCtD
Eszopiclone—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000152	0.00171	CbGpPWpGaD
Eszopiclone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000462	CcSEcCtD
Eszopiclone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000458	CcSEcCtD
Eszopiclone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00015	0.00169	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00015	0.00169	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00045	CcSEcCtD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00165	CbGpPWpGaD
Eszopiclone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000444	CcSEcCtD
Eszopiclone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000441	CcSEcCtD
Eszopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00163	CbGpPWpGaD
Eszopiclone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000433	CcSEcCtD
Eszopiclone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000142	0.0016	CbGpPWpGaD
Eszopiclone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000429	CcSEcCtD
Eszopiclone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00014	0.00158	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00014	0.00158	CbGpPWpGaD
Eszopiclone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000423	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000405	CcSEcCtD
Eszopiclone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000404	CcSEcCtD
Eszopiclone—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00149	CbGpPWpGaD
Eszopiclone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000402	CcSEcCtD
Eszopiclone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00149	CbGpPWpGaD
Eszopiclone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000399	CcSEcCtD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00148	CbGpPWpGaD
Eszopiclone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000391	CcSEcCtD
Eszopiclone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000386	CcSEcCtD
Eszopiclone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000385	CcSEcCtD
Eszopiclone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000385	CcSEcCtD
Eszopiclone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000383	CcSEcCtD
Eszopiclone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000383	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000126	0.00141	CbGpPWpGaD
Eszopiclone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00038	CcSEcCtD
Eszopiclone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000366	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000363	CcSEcCtD
Eszopiclone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000363	CcSEcCtD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.00134	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.00133	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00131	CbGpPWpGaD
Eszopiclone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000353	CcSEcCtD
Eszopiclone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000351	CcSEcCtD
Eszopiclone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000351	CcSEcCtD
Eszopiclone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000116	0.0013	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000114	0.00129	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000327	CcSEcCtD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.0012	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000107	0.0012	CbGpPWpGaD
Eszopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00119	CbGpPWpGaD
Eszopiclone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000319	CcSEcCtD
Eszopiclone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000314	CcSEcCtD
Eszopiclone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000304	CcSEcCtD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.98e-05	0.00112	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.84e-05	0.00111	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.71e-05	0.00109	CbGpPWpGaD
Eszopiclone—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.000294	CcSEcCtD
Eszopiclone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.6e-05	0.00108	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.47e-05	0.00107	CbGpPWpGaD
Eszopiclone—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000282	CcSEcCtD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.29e-05	0.00104	CbGpPWpGaD
Eszopiclone—Rash—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.00028	CcSEcCtD
Eszopiclone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.00028	CcSEcCtD
Eszopiclone—Headache—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000278	CcSEcCtD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.15e-05	0.00103	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.11e-05	0.00102	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.04e-05	0.00102	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.92e-05	0.001	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.91e-05	0.001	CbGpPWpGaD
Eszopiclone—Nausea—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000264	CcSEcCtD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.66e-05	0.000975	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.57e-05	0.000965	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.46e-05	0.000951	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.42e-05	0.000947	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.12e-05	0.000914	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.01e-05	0.000901	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.9e-05	0.000889	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.7e-05	0.000866	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.62e-05	0.000857	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.61e-05	0.000857	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.54e-05	0.000849	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.53e-05	0.000848	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.48e-05	0.000842	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.36e-05	0.000828	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.35e-05	0.000827	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.35e-05	0.000827	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.26e-05	0.000817	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.22e-05	0.000812	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.07e-05	0.000796	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.04e-05	0.000792	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.02e-05	0.000789	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.98e-05	0.000785	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.9e-05	0.000776	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.88e-05	0.000774	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.88e-05	0.000774	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.46e-05	0.000727	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.4e-05	0.00072	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.33e-05	0.000713	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.25e-05	0.000703	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.16e-05	0.000693	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.61e-05	0.000632	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.49e-05	0.000618	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.28e-05	0.000594	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.22e-05	0.000587	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.21e-05	0.000586	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.1e-05	0.000573	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.06e-05	0.000569	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.92e-05	0.000553	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.85e-05	0.000546	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.79e-05	0.000539	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.62e-05	0.00052	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.6e-05	0.000518	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.57e-05	0.000514	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.54e-05	0.000511	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.53e-05	0.00051	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.49e-05	0.000505	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.44e-05	0.0005	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.41e-05	0.000496	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.33e-05	0.000488	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.23e-05	0.000476	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.13e-05	0.000465	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4e-05	0.00045	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.76e-05	0.000423	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.72e-05	0.000418	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.72e-05	0.000418	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.7e-05	0.000417	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.7e-05	0.000416	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.000415	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.62e-05	0.000407	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.46e-05	0.00039	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.39e-05	0.000382	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.36e-05	0.000378	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.29e-05	0.00037	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.12e-05	0.000352	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.000301	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.61e-05	0.000293	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.57e-05	0.000289	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.45e-05	0.000276	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.43e-05	0.000273	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.4e-05	0.00027	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.39e-05	0.000269	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.39e-05	0.000268	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.000255	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.24e-05	0.000252	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.22e-05	0.00025	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.000246	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.000227	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000222	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.95e-05	0.00022	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.82e-05	0.000205	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.78e-05	0.000201	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.68e-05	0.000189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.66e-05	0.000187	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.64e-05	0.000185	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.55e-05	0.000174	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-05	0.000174	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-05	0.000166	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000165	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000154	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000152	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000147	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000145	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000142	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.19e-05	0.000134	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000132	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000122	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.97e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.53e-06	0.000107	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.03e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.91e-06	0.0001	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.3e-06	9.34e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.11e-06	9.13e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.87e-06	8.85e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.76e-06	8.73e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.35e-06	6.02e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.12e-06	5.76e-05	CbGpPWpGaD
